Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; project period max 2 years.

Summary: Supports translational research to understand the emergence and trajectory of schizophrenia and related psychotic disorders in individuals aged 35 and older, aiming to identify targets for prevention and treatment.

Key Information: Applications must focus on mid- to late-life (≥35 years); non-domestic (non-U.S.) entities are eligible; clinical trial optional; strict data sharing via NIMH Data Archive required.